[Eosinophilic esophagitis]

Presse Med. 2017 Mar;46(2 Pt 1):154-158. doi: 10.1016/j.lpm.2016.09.003. Epub 2016 Oct 10.
[Article in French]

Abstract

Eosinophilic esophagitis is a major cause of dysphagia and esophageal food impaction in young adults, although the diagnostic can be made in older patients. The diagnosis of eosinophilic esophagitis is suspected on endoscopic abnormalities of esophageal mucosa and confirmed by esophageal biopsy samples. Approximately 50% of patients with eosinophilic esophagitis do respond to proton pump inhibitors therapy. The first line therapy for eosinophilic esophagitis is proton pump inhibitor therapy. Ingested topical steroids represent a second-line therapy. The practical modalities of this treatment should be clearly explained to patients. A diet that eliminates most alimentary allergens provide a 75% clinical and histological remission rate. The progressive reintroduction protocol allows to identify the allergen(s) involved in the disease. Endoscopic dilatations should be proposed in patients with significant esophageal stricture.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Age of Onset
  • Deglutition Disorders / etiology
  • Diagnosis, Differential
  • Dilatation
  • Eosinophilic Esophagitis* / complications
  • Eosinophilic Esophagitis* / diagnosis
  • Eosinophilic Esophagitis* / drug therapy
  • Eosinophilic Esophagitis* / epidemiology
  • Esophageal Stenosis / etiology
  • Esophageal Stenosis / therapy
  • Esophagoscopy
  • Food Hypersensitivity / complications
  • Food Hypersensitivity / diet therapy
  • Gastroesophageal Reflux / diagnosis
  • Humans
  • Proton Pump Inhibitors / therapeutic use
  • Young Adult

Substances

  • Adrenal Cortex Hormones
  • Proton Pump Inhibitors